5/2/2011 10:00:00 AM
LifeNet® mosquito nets receive interim recommendation from World Health Organization
LifeNet is the first innovation in this field for more than a decade: deltamethrin, the active ingredient recommended by the WHO, has been directly integrated into polypropylene fibres for the first time. It is gradually released while continuously exerting its insecticidal action. Thanks to the soft but very tear-resistant polypropylene fibres, LifeNet is longer-lasting and at the same time user friendly - it thereby ensures sustainable long-term protection.
“The interim recommendation from the Pesticide Evaluation Scheme of the WHO (WHOPES) now makes it possible for us to offer national and international malaria control programs a new tool in the battle against malaria,” explains Dr. Gunnar Riemann, President of the Environmental Science Division at Bayer CropScience. “We are convinced that LifeNet will help public health authorities and aid organizations around the world achieve sustained success in the battle against malaria.”
Bayer looks back on more than 50 years of experience in the field of vector control. With the forthcoming market launch of LifeNet, the company will now be in the position to offer a broad portfolio for integrated vector management.
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience, a subgroup of Bayer AG with annual sales of EUR 6.830 billion (2010), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 20,700 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.